Month: March 2022

Global technology leader signs 328,000 square foot, 16-year lease to establish new NYC Hub in Manhattan’s Flatiron District NEW YORK, March 15, 2022 (GLOBE NEWSWIRE) — SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced that International Business Machines Corporation (“IBM”) has signed a 16-year, 328,000 square foot lease at One Madison Avenue covering portions of floors 2 and 7, entire floors 8 through 10 and a portion of the ground floor where IBM will have an exclusive lobby entrance creating a building within a building experience. This lease follows the recently announced 20-year, 56,000 square foot lease with Chelsea Piers Fitness. One Madison Avenue is SL Green’s latest world-class development scheduled for completion in November 2023. The 1.4 million square-foot Midtown South office...

SAN DIEGO, March 15, 2022 (GLOBE NEWSWIRE) — Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that it will host a virtual Investor R&D Event from 10 a.m. – Noon ET on March 22, 2022. This event will include presentations by key opinion leaders who will provide background information on tinnitus and hearing loss, and review the positive Phase 1/2 trial results for Otonomy’s OTO-313 and OTO-413 product candidates that target these conditions. Additionally, members of Otonomy’s senior management team will provide an update on ongoing clinical trials and outline next steps for these programs. External speakers participating in this event include:Barbara Shinn-Cunningham, Ph.D., Director, Carnegie Mellon Neuroscience Institute...

Figure 1 Tête Nord LocationFigure 2 Heliborne EM SurveyFigure 3 Savane Magmatic SystemFigure 4 Rochette ShowingMONTREAL, March 15, 2022 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the commencement of an important helicopter-borne electromagnetic VTEM-type (“VTEM”) survey covering the Tete Nord nickel-copper (“Ni-Cu”) property. This property, currently wholly owned by Midland, is subject to an option agreement signed in December 2021 with Rio Tinto Exploration Canada Inc. (“RTEC”) and is located near the town of La Tuque in Quebec. Regional VTEM survey The VTEM survey is scheduled to begin mid-March and will total approximately 6,700-line kilometres, covering the entire property under option with flight lines at a 100-metre spacing. A budget of $900,000 has been set...

LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical research, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in Maxim Group’s 2022 Virtual Growth Conference to be held virtually on March 28-30, 2022. Dr. Ianelli’s corporate presentation will be available on-demand starting Monday, March 28, 2022, at 9:00 a.m. ET for all registrants of the virtual conference. To attend, please register here. For more information about the Maxim conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your appropriate Maxim representative directly, or send an...

GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it will present MRD (molecular residual disease) clinical data on non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) at the following two sessions of American Association for Cancer Research (AACR) Annual Meeting on April 8, 2022:5916 – Tumor-informed patient-specific panel outperforms tumor-naïve and tumor-informed fixed panel for circulating tumor DNA (ctDNA)-based postoperative monitoring of non-small cell lung cancer (NSCLC); and 5917 – Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for postoperative monitoring of patients with stages I-III colorectal cancer (CRC).“We are excited to present the first set of data on our proprietary...

REHOVOT, Israel, March 15, 2022 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, today issued the Letter to Shareholders from Amir London, Chief Executive Officer. March 15th, 2022 Dear Shareholders, Colleagues and Business Partners: The recently completed 2021 year was a transformational period for Kamada in our path toward becoming a global leader in the plasma-derived specialty market. Following the completion of the planned manufacturing transition of Glassia® to Takeda, our recent acquisition of four FDA-approved commercial immunoglobulins and the establishment of Kamada Plasma, our U.S. based plasma collection company, we are embarking on a new and exciting chapter in the Company’s evolution. We are building...

EVANSVILLE, Ind. and CHICAGO, March 15, 2022 (GLOBE NEWSWIRE) — Old National Bank (NASDAQ: ONB) today announced it has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as one of the 2022 World’s Most Ethical Companies. The recognition honors companies demonstrating exceptional leadership and a commitment to business integrity through best-in-class ethics, compliance and governance practices. Old National has been recognized for 11 consecutive years and is one of only three U.S. banks recognized and one of five honorees in the banking industry worldwide. In 2022, 136 honorees were recognized spanning 22 countries and 45 industries. “We are extremely proud to be honored as one of the World’s Most Ethical Companies for the 11th consecutive year,” said...

LA JOLLA, Calif., March 15, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Geoffrey O’Brien, JD/MBA, Vice President and Executive Officer, will present a corporate overview at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28 – 30, 2022 from 9:00 a.m. – 5:00 p.m. EDT. About MediciNova MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for inflammatory, fibrotic and neurodegenerative diseases. Based on two compounds, MN-166 (ibudilast) and MN-001 (tipelukast), with multiple mechanisms of action and strong safety profiles, MediciNova...